Skip to main content
Livermore
Livermore
ZHEN

ProShare Advisors LLC

SEC CIK
0001357955
Latest filing
Aug 11, 2026

ALLO holding history

Allogene Therapeutics, Inc. in every 13F filed by ProShare Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ALLO overviewAll 13F holders of ALLOFull Q2 2026 holdings

Shares (Q2 2026)
46,070
Value
$95.8K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of ALLO by ProShare Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202646,070$95.8K<0.1%+13,432+41.2%AddedHolders
Q1 202632,638$79.6K<0.1%−5,396−14.2%ReducedHolders
Q4 202538,034$52.1K<0.1%+4,204+12.4%AddedHolders
Q3 202533,830$41.9K<0.1%−5,430−13.8%ReducedHolders
Q2 202539,260$44.4K<0.1%+2,014+5.4%AddedHolders
Q1 202537,246$54.4K<0.1%−8,836−19.2%ReducedHolders
Q4 202446,082$98.2K<0.1%+9,388+25.6%AddedHolders
Q3 202436,694$102.7K<0.1%+11,149+43.6%AddedHolders
Q2 202425,545$59.5K<0.1%−3,224−11.2%ReducedHolders
Q1 202428,769$128.6K<0.1%+2,377+9.0%AddedHolders
Q4 202326,392$84.7K<0.1%+4,759+22.0%AddedHolders
Q3 202321,633$68.6K<0.1%+1,509+7.5%AddedHolders
Q2 202320,124$100.0K<0.1%+726+3.7%AddedHolders
Q1 202319,398$95.8K<0.1%−2,783−12.5%ReducedHolders
Q4 202222,181$139.5K<0.1%+1,297+6.2%AddedHolders
Q3 202220,884$225.0K<0.1%−475−2.2%ReducedHolders
Q2 202221,359$243.0K<0.1%−7,862−26.9%ReducedHolders
Q1 202229,221$266.0K<0.1%−7,554−20.5%ReducedHolders
Q4 202136,775$549.0K<0.1%−4,062−9.9%ReducedHolders
Q3 202140,837$1.05M<0.1%−4,639−10.2%ReducedHolders
Q2 202145,476$1.19M<0.1%+10,365+29.5%AddedHolders
Q1 202135,111$1.24M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.